References
- Hug BL, Lipsitz SR, Seger DL, Karson AS, Wright SC, Bates DW. Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease. Swiss Med Wkly 2009; 139: 737-46.
- Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013; 59: 160-8. 10.1016/j.jhep.2013.03.00723511777
- [Internal medicine]. [Slovenian]. Third edition. Kocijančič A, Mrevlje F, Štajer D, editors. Ljubljana: Literra picta; 2005. p. 592-619.
- [Internal medicine]. [Slovenian]. Košnik M, Mrevlje F, Štajer D, Koželj M, Černelč P. Editors. Ljubljana: Literra picta; 2011; 663. p. 669-72.
- Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison’s principles of internal medicine Volume II. New York: McGraw-Hill Medical; 2008. p. 233, 1969-78, 1982-3.
- Magdaleno F, Blajszczak CC, Nieto N. Key events participating in the pathogenesis of alcoholic liver disease. Biomolecules 2017; 9: 1-14. 10.3390/blom7010009
- Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Sem Liver Disease 1988; 8: 12-25.10.1055/s-2008-1040525
- Petrides AS: Liver disease and diabetes mellitus. Diabet Rev 1994; 2: 2-18.
- Asbert M, Gines A, Gines P, Jiménez W, Clària J, Saló J, et al. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993; 104: 1485-91.10.1016/0016-5085(93)90360-O8482460
- Baig NA, Herrine SK, Rubin R. Liver disease and diabetes mellitus. Clin Lab Med 2001; 21: 193-207.11321935
- Gentilini P, Romanelli RG, Laffi G, Barletta G, Del Bene R, Messeri G, et al. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999; 30: 632-8.10.1016/S0168-8278(99)80193-710207804
- Spatt SD, Rosenblatt P. The incidence of hypertension in portal cirrhosis: a study of 80 necropsied cases of portal cirrhosis. Ann Int Med 1949; 31: 479-83.10.7326/0003-4819-31-3-479
- Loyke HF. The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Am J Med Sci 1955; 230: 627-32.1326844010.1097/00000441-195523060-00004
- Veglio F, Pinna G, Melchio R, Rabbia F, Panarelli M, Schiavone D, et al. Hormonal aspects of the relation of liver cirrhosis to essential hypertension. Clin Exp Hypertens A 1992; 14: 889-903.1395076
- Raaschou F. Blood pressure and heart weight in chronic hepatitis. Does the liver play a role in the development of essential hypertension? Nord Med 1949; 46: 1791-95.
- Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-90. 10.1056/NEJMra080913919776409
- Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-36.10.1016/0016-5085(93)90031-78514039
- Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011; 17: 1237-48. 10.3748/wjg.v17.i10.123721455322
- Bernardi M, Servadei D, Trevisani F, Rusticali AG, Gasbarrini G. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites. Digestion 1985; 31: 189-93.10.1159/0001991984007290
- Pérez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983; 84: 961-8.6339312
- Gatta A, Angeli P, Caregaro L, Menon F, Sacerdoti D, Merkel C. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology 1991; 14: 231-36.10.1002/hep.1840140205
- Power C, Rodgers B, Hope S. U-shaped relation for alcohol consumption and health in early adulthood and implications for mortality. Lancet 1998, 352: 877.10.1016/S0140-6736(98)23937-79742982
- Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006; 166: 2437. 10.1001/archinte.166.22.243717159008
- Edmondson HA: Pathology of alcoholism. Am J Clin Pathol 1980; 74: 725-42,625579010.1093/ajcp/74.5.725
- Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 2010; 51: 1675-82. 10.1002/hep.2350020186844
- Galambos JT. Alcoholic hepatitis: Its therapy and prognosis. Prog Liver Dis 1972; 4: 567-88.4569010
- Pares A, Caballeria J, Bruguera M. Histological course of alcoholic hepatitis: Influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986; 2: 33-42.395036210.1016/S0168-8278(86)80006-X
- Morgan, MY. The prognosis and outcome of alcoholic liver disease. Alcohol Suppl 1994; 2: 335-43.
- Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol 2011; 4: 63-81. 10.1177/1756283X1037892521317995
- O’Shea RS, Dasarathy S, and McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010; 105: 14-32; 10.1038/ajg.2009.59319904248
- Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J Hepatol 2012; 4: 81-90. 10.4254/wjh.v4.i3.8122489260
- Wigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol 2013; 11: 850-8. 10.1016/j.cgh.2013.01.015423375997